BOSTON, MA, UNITED STATES, January 8, 2026 /EINPresswire.com/ -- EyeCool Therapeutics, a clinical-stage ophthalmic ...

Mammals aren’t known for the ocular regenerative powers, but a new study shows that nature has a few tricks up its sleeve.

Conjunctivitis or episcleritis and scleritis comprised the most common eye manifestations, while cataracts (11.7%) and visual ...

Company on track to report ELEVATE-44-201 data from the first cohort in Q2 2026 and ELEVATE-45-201 data from the first cohort in mid-2026 –-- ...

Signs and symptoms of ocular surface disease could be significantly reduced within 4 days after treatment with shelf-stable ...

If you are wondering whether Ocular Therapeutix at around US$11.25 still offers value or if most of the opportunity is already priced in, you are asking the right question. The stock has been volatile ...

Patients who experience adverse ocular effects with bisphosphonates have a notably higher risk for osteonecrosis than those who do not experience such events, a large cohort study shows.

Ocular albinism is a genetic condition that involves the eyes. This condition reduces the pigmentation of the iris — the colored part of the eye — and the retina, causing vision problems. Albinism is ...

Ophthalmology biopharmaceutical company Ocular Therapeutix (NASDAQ:OCUL) reported Q3 CY2025 results , but sales fell by 5.7% ...

Background/Aims On 17 September 2024, over 3000 pager devices containing explosives were remotely detonated across Lebanon in ...

An ocular migraine (also called a retinal migraine) is a rare type of migraine headache that causes visual symptoms in one of your eyes. The problem isn't with your eyes; it's a problem with the way ...

When it comes to migraines, not all headaches are created the same. According to Joey Gee, D.O., neurologist with Providence Mission Hospital, approximately 15 to 25% of migraine sufferers will ...